| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 06/23/2004 | CN1506105A Chinese patent medicine for preventing and treating post-operation blood stasis and its prepn process |
| 06/17/2004 | WO2004050056A1 Cochlear implant drug delivery device |
| 06/17/2004 | US20040116438 Compositions for treatment of cell proliferation disorders |
| 06/17/2004 | US20040115139 Botulinum toxin dental therapies and procedures |
| 06/16/2004 | EP1428832A2 Peptide and O-glycan inhibitors of selectin mediated inflammation |
| 06/16/2004 | CN1153585C Instant traditional Chinese medicine for treating intestinal adhesion and its preparing process |
| 06/10/2004 | WO2003072027A3 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof |
| 06/10/2004 | US20040110832 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 06/09/2004 | EP1426375A2 Analgesic spiroindole derivatives |
| 06/09/2004 | CN1502368A Application of recombinant adenovirus in treating cerebral ischemia, traumatic restoration and tissue adhesion |
| 06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 06/02/2004 | CN1501940A Composition and method for inhibiting platelet aggregation |
| 06/01/2004 | US6743774 Tribonectins |
| 05/27/2004 | US20040102615 Method for isolating and purifying a protein and resulting protein |
| 05/27/2004 | US20040102441 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 05/27/2004 | US20040101962 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 05/26/2004 | EP1420801A1 Use of fucans in the treatment of adhesions, arthritis and psoriasis |
| 05/20/2004 | US20040097469 For prophylaxis of cartilage destruction or chondrolysis associated with osteonecrosis and/or osteochondritis dissecans |
| 05/20/2004 | US20040096513 Systemically minimizing the inflammatory effects of TNF- alpha are disclosed. The compositions include particles of bioactive glass with a particle size less than about 20 mu m, alone or in combination with anti-inflammatory agents and |
| 05/19/2004 | EP1419256A2 Conjugates for the modulation of immune responses |
| 05/18/2004 | US6737426 Such as (4-phenylsulfonyl-2-pyridin-3-yl-oxazol-5-yl)-methylamine; anticonvulsants, antiinflammatories, neuro-protectants, cerebroprotectants, nootropics |
| 05/13/2004 | WO2004039395A1 Immunnoevasive agent for preventing graft rejection |
| 05/12/2004 | EP1417228A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417227A2 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417055A2 Use of copper chelators to inhibit the inactivation of protein c |
| 05/12/2004 | EP1416941A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 05/11/2004 | US6732738 Method to enhance healing of sternum after sternotomy |
| 05/06/2004 | WO2004037280A1 Angiogenesis inducer |
| 05/06/2004 | US20040087800 Spirooxindole derivatives are analgesics for the treatment of chronic pain. |
| 05/06/2004 | US20040087510 Cardiovascular diseases and disorders; sustained delivery of nitric oxide |
| 05/06/2004 | EP1414480A1 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 05/06/2004 | CA2502453A1 Angiogenesis inducer |
| 05/04/2004 | US6730489 Antibodies to truncated VEGF-D and uses thereof |
| 05/04/2004 | US6730299 Kit; simple, practical; bioresorbable, nontoxic wound protection; biocompatible fluid and gas; produces foam |
| 04/29/2004 | WO2004035070A1 Induction of gene expression using a high concentration sugar mixture |
| 04/29/2004 | WO2004035011A2 Botulinum toxin dental therapies and procedures |
| 04/29/2004 | US20040082540 Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis |
| 04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
| 04/29/2004 | CA2501856A1 Botulinum toxin dental therapies and procedures |
| 04/29/2004 | CA2498213A1 Induction of gene expression using a high concentration sugar mixture |
| 04/28/2004 | CN1491720A Inducer of blood vessel neogenesis |
| 04/28/2004 | CN1147289C Method and compositions for stabilizing acetylcholine compositions |
| 04/27/2004 | US6727258 Allosteric adenosine receptor modulators |
| 04/27/2004 | CA2230530C Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives |
| 04/22/2004 | WO2004033681A1 Substance having activity of promoting platelet aggregation |
| 04/22/2004 | WO2004017948A3 Use of lck inhibitor for treatment of immunologic diseases |
| 04/22/2004 | US20040077684 Piperidinyl compounds that selectively bind integrins |
| 04/22/2004 | US20040077630 Allosteric adenosine receptor modulators |
| 04/21/2004 | EP1409535A2 Human secreted proteins |
| 04/21/2004 | CN1489993A Use of archin and extracts containing archin in recovery of enterogastric functions after operation and prevention of intestinal edhension |
| 04/20/2004 | US6723709 Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives |
| 04/15/2004 | US20040073280 Method of controlling body temperature while reducing shivering |
| 04/15/2004 | US20040071711 Imaging, diagnosis and treatment of disease |
| 04/14/2004 | EP1406866A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/14/2004 | EP1406700A1 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 04/14/2004 | EP1406664A2 Targeting chemical compounds to cells |
| 04/14/2004 | EP1406626A2 Sulphonyl aryl hydroxamates and their use as mmp inhibitors |
| 04/14/2004 | EP1202994B1 New compounds |
| 04/14/2004 | CN1489573A Perfluoronated cycle-containing tertiary amines used as basis for gas-conveying emulsions and preparation method |
| 04/14/2004 | CN1489473A Silensed anti-CD 28 antibodies and use thereof |
| 04/13/2004 | US6719960 Use of phospholipids for the manufacture of a medicament for the prevention of adhesions |
| 04/08/2004 | WO2003011313A8 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 04/07/2004 | EP1404815A2 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 04/07/2004 | CN1487967A A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 04/07/2004 | CN1487843A A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
| 04/07/2004 | CN1487835A Composition of hypochlorous acid and its applications |
| 04/03/2004 | WO2003026711A1 Polyfunctional biocompatible hydrogel and method for the production thereof |
| 04/01/2004 | WO2004026320A1 Vitreoretinal tamponades based on fluorosilicone fluids |
| 04/01/2004 | WO2003075953A3 Immunomodulatory polymeric antigens for treating inflammatory pathogies |
| 04/01/2004 | US20040063644 Urea and urethane derivatives as integrin inhibitors |
| 04/01/2004 | US20040062818 Composition of hypochlorous acid and its applications |
| 04/01/2004 | CA2499859A1 Vitreoretinal tamponades based on fluorosilicone fluids |
| 03/31/2004 | EP1402906A1 Synechia inhibitory material |
| 03/31/2004 | EP1401506A2 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy |
| 03/31/2004 | EP1401441A2 Allosteric adenosine receptor modulators |
| 03/31/2004 | EP1218026B1 Preparation of a medicament to enhance healing of the sternum after sternotomy |
| 03/31/2004 | EP0873130B1 Compositions comprising pvp having an average molecular weight in the range of 7.000 to 12.000 daltons |
| 03/31/2004 | EP0784677B1 Inhibitor of stem cell proliferation and uses thereof |
| 03/25/2004 | WO2004024168A1 Composition and method for use in intestinal cleansing procedures |
| 03/25/2004 | WO2004013138A3 Imidazo`1,2-a!pyridines |
| 03/25/2004 | WO2003084941A3 Hydroxamic acid derivatives |
| 03/25/2004 | US20040059383 Methods of indirectly stimulating the vagus nerve with an electrical field |
| 03/25/2004 | US20040058994 Local prevention or amelioration of pain from surgically closed wounds |
| 03/24/2004 | EP1399175A2 Therapeutic use of rank antagonists |
| 03/24/2004 | EP1399147A2 Therapeutic delivery of carbon monoxide |
| 03/24/2004 | EP1143964B1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission |
| 03/24/2004 | CN1484537A Pharmacentical preparation for douches and/or irrigations of natural or puthological cavities in human body |
| 03/24/2004 | CN1142789C Injectable compositions for soft tissue augmentation |
| 03/23/2004 | US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/18/2004 | US20040054184 Preservative for organs, synthetic blood |
| 03/18/2004 | US20040053890 Naphthalene derivatives |
| 03/17/2004 | EP1397167A2 Wound closure system and methods |
| 03/16/2004 | US6706731 With isoquinoline derivatives as antitumor agents |
| 03/11/2004 | WO2004020435A1 Piperidinyl compounds that selectively bind integrins |
| 03/11/2004 | WO2004020415A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 03/11/2004 | WO2002070594A8 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 03/11/2004 | WO2002058750A8 A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
| 03/11/2004 | WO2002058749A8 Carrier with solid fibrinogen and solid thrombin |
| 03/11/2004 | US20040047900 Treatment of posterior capsule opacification |
| 03/11/2004 | CA2495853A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12 |